ABG Commercial Realty  |  (617) 492 9900

View Saved Properties  |   Sign Up

Biomedical Testing Facility Coming to Malden Center

$385,500/SOLD
Please enter your starting address in the form input below.

In Vitro Biomedical Testing Facility coming to Malden Center

Peter Mayfield of ABG Realty recently represented the seller in the transaction of 389 Main Street in Malden for $385,500. Thayer Morgan of Century 21 represented the property's buyer, In Vitro ADMET Laboratories LLC. 7,236 square feet of office and lab space was sold to the Maryland-based pharma company. In Vitro offers products and contract services that represent three decades of expertise in the application of in vitro experimental systems to evaluate drug absorption, metabolism, drug-drug interactions and drug toxicity.

IVAL intends to use the space at 389 Main St as a new biomedical testing facility. Conveniently situated in the heart of the Malden Center, this building is easily accessible by MBTA public transport, making it easy for employees to commute to work. In Vitro is excited about its new testing location, which it hopes will further expedite the drug development process. By offering a new location for drug testing, the company will look to improve the efficiency of this aspect of its business so it can focus more on areas such as R&D.


Rent/SF/Year
SOLD
Parking Spaces
4 Dedicated Spaces
Auto Traffic
Heavy
Public Transp
MBTA Train & T Stops
Property Type
Office

If you would like to send this property to a friend that you think may be interested, please complete the form below. To send this property to multiple friends, enter each email separated by a comma in the 'Friends Email' field.

Please complete the form below to request a showing for this property. We will review your request and respond to you as soon as possible. Please add any additional notes or comments that we will need to know about your request.

LET US HELP YOU FIND PROPERTIES OF INTEREST.

Best Commercial Real Estate Advice
to Increase Your Investment Returns? Sign-up below...

Get the latest CRE News, Market Trends & Insights to make the best decisions.
Subscribe to our monthly newsletter! Let us better serve you.


First Name
Invalid Input

Last Name
Invalid Input

Email(*)
Invalid Input

Phone
Invalid Input

Preferred Email

Invalid Input
Invalid Input
Invalid Input

We hate SPAM and promise to keep your email address safe.